Skip to main content
Clinical Trials/NCT01637038
NCT01637038
Completed
Not Applicable

The Effect of Remote Ischemic Postconditioning on Liver Graft and Renal Function in Patients Undergoing Living-related Liver Transplantation

Samsung Medical Center1 site in 1 country80 target enrollmentJune 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Ischemia/Reperfusion Injury of Liver Graft
Sponsor
Samsung Medical Center
Enrollment
80
Locations
1
Primary Endpoint
total bilirubin
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

The investigators are trying to evaluate the clinical effect of remote ischemic postconditioning on liver graft function and postoperative renal function in subjects undergoing living-donor liver transplantation.

Detailed Description

Ischemic reperfusion injury of liver graft and postoperative renal dysfunction is a common problem which influence poor outcome in subjects undergoing liver transplantation. The incidence of postoperative renal dysfunction was reported as high as 12 \~ 64% and is thought to be caused by ischemia/reperfusion injury. Ischemic pre- or postconditioning was reported to be effective for preventing ischemia/reperfusion injury during liver transplantation. Remote ischemic pre- or postconditioning was also reported to be protective for ischemia/reperfusion injury in major organs in previous animal studies. Therefore, we are trying to evaluate the clinical effect of remote ischemic postconditioning on liver graft function and postoperative renal function in subjects undergoing living-donor liver transplantation.

Registry
clinicaltrials.gov
Start Date
June 2012
End Date
February 2013
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jong Hwan Lee

Assistant Professor

Samsung Medical Center

Eligibility Criteria

Inclusion Criteria

  • Subjects undergoing living donor liver transplantation during the study period
  • Subjects older than 20 yrs who can give written informed consent

Exclusion Criteria

  • Re-transplanted recipients
  • Those with peripheral vascular diseases affecting the extremities
  • Those with hepatic encephalopathy
  • Those with cirrhotic cardiomyopathy

Outcomes

Primary Outcomes

total bilirubin

Time Frame: before surgery and at 6, 12, 24, 36, 48, 60, 72, 84, 96 hours after the end of surgery

total bilirubin before surgery and at 6, 12, 24, 36, 48, 60, 72, 84, 96 hours after the end of surgery

Secondary Outcomes

  • Renal Function Test profiles(Before surgery and at 6, 12, 24, 36, 48, 60, 72, 84, 96 hours after the end of surgery)
  • Liver Function Test Profiles(before surgery and at 6, 12, 24, 36, 48, 60, 72, 84, 96 hours after the end of surgery)
  • incidence of Surgical Outcome(1 week, 1 month after the end of surgery)
  • Length of hospital stay (days)(1 month, 2 month, 3 month after the end of surgery)

Study Sites (1)

Loading locations...

Similar Trials